Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

2.

An interview with William A. Haseltine.

Haseltine WA.

Rejuvenation Res. 2004 Fall;7(3):229-31. No abstract available.

PMID:
15588523
3.

A tribute to Dr. William A. Haseltine. Interview by Val J. Halamandaris.

Haseltine WA.

Caring. 2003 Dec;22(12):54-66. No abstract available.

PMID:
14674196
4.

Beyond chicken soup.

Haseltine WA.

Sci Am. 2001 Nov;285(5):56-63. No abstract available. Erratum in: Sci Am 2002 Mar;286(3):14.

PMID:
11681176
5.

Genomics and drug discovery.

Haseltine WA.

J Am Acad Dermatol. 2001 Sep;45(3):473-5.

PMID:
11511852
6.

Of genes and genomes: what lies between the base pairs.

Collins FS, Haseltine WA.

J Investig Med. 2000 Sep;48(5):295-301. No abstract available.

PMID:
10979234
7.

Not quite pharmacogenomics.

Haseltine WA.

Nat Biotechnol. 1998 Dec;16(13):1295. No abstract available.

PMID:
9853593
8.

The power of genomics to transform the biotechnology industry.

Haseltine WA.

Nat Biotechnol. 1998 May;16 Suppl:25-7. No abstract available.

PMID:
9591259
9.

Flow of novel genes for R&D continues.

Haseltine WA.

Nature. 1998 Feb 26;391(6670):834. No abstract available.

PMID:
9495330
10.

Discovering genes for new medicines.

Haseltine WA.

Sci Am. 1997 Mar;276(3):92-7. No abstract available.

PMID:
9046111
11.

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Uberla K, Stahl-Hennig C, Böttiger D, Mätz-Rensing K, Kaup FJ, Li J, Haseltine WA, Fleckenstein B, Hunsmann G, Oberg B, et al.

Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8210-4.

12.

Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.

Friborg J, Ladha A, Göttlinger H, Haseltine WA, Cohen EA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):10-22.

PMID:
8548340
13.
14.

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.

Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, et al.

Nature. 1994 Sep 1;371(6492):75-80.

PMID:
8072530
15.

Mutation of a mutL homolog in hereditary colon cancer.

Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, et al.

Science. 1994 Mar 18;263(5153):1625-9.

PMID:
8128251
16.

Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.

Lavallée C, Yao XJ, Ladha A, Göttlinger H, Haseltine WA, Cohen EA.

J Virol. 1994 Mar;68(3):1926-34.

17.
18.

Genetic analysis of the human immunodeficiency virus type 1 integrase protein.

Shin CG, Taddeo B, Haseltine WA, Farnet CM.

J Virol. 1994 Mar;68(3):1633-42.

19.
20.
21.
22.
23.

Effect of nef alleles on replication of human immunodeficiency virus type 1.

Zazopoulos E, Haseltine WA.

Virology. 1993 May;194(1):20-7.

PMID:
7683154
24.

The NF-kappa B p65 promoter.

Ueberla K, Lu Y, Chung E, Haseltine WA.

J Acquir Immune Defic Syndr. 1993 Mar;6(3):227-30.

PMID:
8450395
25.
26.

Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression.

McGuire KL, Curtiss VE, Larson EL, Haseltine WA.

J Virol. 1993 Mar;67(3):1590-9.

27.

Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.

Shilatifard A, Merkle RK, Helland DE, Welles JL, Haseltine WA, Cummings RD.

J Virol. 1993 Feb;67(2):943-52.

28.

The effect of vpu on HIV-1-induced syncytia formation.

Yao XJ, Garzon S, Boisvert F, Haseltine WA, Cohen EA.

J Acquir Immune Defic Syndr. 1993 Feb;6(2):135-41.

PMID:
8094456
30.

Infection of accessory dendritic cells by human immunodeficiency virus type 1.

Langhoff E, Haseltine WA.

J Invest Dermatol. 1992 Nov;99(5):89S-94S. Review.

PMID:
1431241
31.

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.

Gabuzda DH, Lawrence K, Langhoff E, Terwilliger E, Dorfman T, Haseltine WA, Sodroski J.

J Virol. 1992 Nov;66(11):6489-95.

32.

Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck.

Repke H, Barber E, Ulbricht S, Buchner K, Hucho F, Kopp R, Scholz H, Rudd CE, Haseltine WA.

J Immunol. 1992 Oct 15;149(8):2585-91.

PMID:
1401895
33.

Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Marasco WA, Bagley J, Zani C, Posner M, Cavacini L, Haseltine WA, Sodroski J.

J Clin Invest. 1992 Oct;90(4):1467-78.

34.

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

Lo KM, Biasolo MA, Dehni G, Palú G, Haseltine WA.

Virology. 1992 Sep;190(1):176-83.

PMID:
1529527
35.

The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.

Göttlinger HG, Dorfman T, Cohen EA, Haseltine WA.

Virology. 1992 Aug;189(2):618-28.

PMID:
1641982
36.
37.

Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function.

Zazopoulos E, Haseltine WA.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6634-8.

38.

Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.

Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U.

J Virol. 1992 Jul;66(7):4570-5.

39.

Reexamination of the coding potential of the HTLV-1 pX region.

Caputo A, Haseltine WA.

Virology. 1992 Jun;188(2):618-27.

PMID:
1585637
40.

An amino-terminal amino acid affects the electrophoretic mobility of the HIV-1 nef protein.

Obaru K, DeClue JE, Haseltine WA.

J Acquir Immune Defic Syndr. 1992;5(3):308-12.

PMID:
1740757
41.

Regulatory genes of human immunodeficiency viruses.

Wong-Staal F, Haseltine WA.

Mol Genet Med. 1992;2:189-219. Review. No abstract available.

PMID:
1458225
42.

Circularization of human immunodeficiency virus type 1 DNA in vitro.

Farnet CM, Haseltine WA.

J Virol. 1991 Dec;65(12):6942-52.

43.

Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1.

Terwilliger EF, Langhoff E, Gabuzda D, Zazopoulos E, Haseltine WA.

Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10971-5.

44.

gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.

Merkle RK, Helland DE, Welles JL, Shilatifard A, Haseltine WA, Cummings RD.

Arch Biochem Biophys. 1991 Oct;290(1):248-57.

PMID:
1898096
45.

Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Langhoff E, Terwilliger EF, Bos HJ, Kalland KH, Poznansky MC, Bacon OM, Haseltine WA.

Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7998-8002.

46.

Transcellular transactivation by the human immunodeficiency virus type 1 tat protein.

Helland DE, Welles JL, Caputo A, Haseltine WA.

J Virol. 1991 Aug;65(8):4547-9.

47.

Molecular biology of the human immunodeficiency virus type 1.

Haseltine WA.

FASEB J. 1991 Jul;5(10):2349-60. Review.

PMID:
1829694
48.

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Göttlinger HG, Dorfman T, Sodroski JG, Haseltine WA.

Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9.

49.

Rex-dependent nucleolar accumulation of HTLV-I mRNAs.

Kalland KH, Langhoff E, Bos HJ, Göttlinger H, Haseltine WA.

New Biol. 1991 Apr;3(4):389-97.

PMID:
2065024
50.

Supplemental Content

Loading ...
Support Center